Cargando…

Use of ultrasound combined with magnetic resonance imaging for diagnosis of breast masses and fibroids

OBJECTIVE: To investigate the clinical value of ultrasound plus magnetic resonance imaging (MRI) for the diagnosis of breast masses and fibroids. METHODS: Clinical data for 357 patients with breast masses diagnosed at our hospital were analyzed retrospectively. The diagnostic performances were compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Wei, Huang, Zihui, Tang, Chenhu, Shen, Bo, Yu, Qun, Niu, Xiaohong, Meng, Fanrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683940/
https://www.ncbi.nlm.nih.gov/pubmed/31155996
http://dx.doi.org/10.1177/0300060519848611
Descripción
Sumario:OBJECTIVE: To investigate the clinical value of ultrasound plus magnetic resonance imaging (MRI) for the diagnosis of breast masses and fibroids. METHODS: Clinical data for 357 patients with breast masses diagnosed at our hospital were analyzed retrospectively. The diagnostic performances were compared between 243 patients who underwent routine ultrasound examinations (control group) and 114 patients who underwent routine ultrasound plus MRI (test group). RESULTS: The overall accordance rates of routine ultrasound and routine ultrasound plus MRI for the diagnosis of breast masses, based on postoperative pathological diagnoses, were 70.78% (172/243) and 90.35% (103/114). The addition of MRI significantly improved the overall diagnostic performance of routine ultrasound for breast masses. The diagnostic accordance rate of routine ultrasound for the diagnosis of breast fibroids (fibroadenomas) was 74.12% (63/85 cases) compared with 93.94% (31/33 cases) for routine ultrasound plus MRI. The diagnostic performance of routine ultrasound plus MRI was therefore also significantly higher than routine ultrasound alone for diagnosing breast fibroids. CONCLUSIONS: Routine ultrasound plus MRI can greatly improve the diagnostic accordance rates for breast masses and fibroadenomas.